Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Mar-17 12:29 PM View:  | Skwierczynski Raymond Head,Pharmaceutical Operations | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 3,615 | $46.50 | $168,098.00 | (100%) 3.62K to 0 | |
| 01-Mar-17 12:12 PM View: | Dallas Matthew D Chief Financial Officer | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition | 37,500 | $46.50 | $1,743,750.00 | (93%) 40.21K to 2.71K | (< 1%) |
| 01-Mar-17 12:12 PM View: | Dallas Matthew D Chief Financial Officer | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 2,708 | $46.50 | $125,922.00 | (100%) 2.71K to 0 | (< 1%) |
| 01-Mar-17 12:20 PM View: | Marengere Luc Director 10% Owner | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 1,545,390 | $46.50 | $71,860,400.00 | (100%) 1.55M to 0 | |
| 01-Mar-17 12:22 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 173,519 | $46.50 | $8,068,630.00 | (100%) 173.52K to 0 | |
| 01-Mar-17 12:14 PM View: | Kuca Bernice Head,Clin. and Reg. Operations | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition | 37,500 | $46.50 | $1,743,750.00 | (93%) 40.23K to 2.73K | |
| 01-Mar-17 12:14 PM View: | Kuca Bernice Head,Clin. and Reg. Operations | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 2,729 | $46.50 | $126,898.00 | (100%) 2.73K to 0 | |
| 01-Mar-17 12:22 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition | 83,000 | $46.50 | $3,859,500.00 | (32%) 256.52K to 173.52K | |
| 01-Mar-17 3:34 PM View: | Pappas Arthur M Director 10% Owner | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Mar-17 | Disposition (change in control) | 1,992,890 | $46.50 | $92,669,600.00 | (100%) 1.99M to 0 | |
| 05-Jan-17 4:37 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Jan-17 | Option Exercise | 3,755 | -- | -- | 1% 254.27K to 258.02K | |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Jan-17 | Market Option Sale (Planned) | 1,677 | $34.59 | $58,010.60 | (100%) 1.68K to 0 | (34%) |
| 05-Jan-17 4:37 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Jan-17 | Market Option Sale (Planned) | 1,502 | $34.78 | $52,237.90 | (< 1%) 258.02K to 256.52K | (33%) |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Jan-17 | Option Exercise | 1,677 | $10.00 | $16,770.00 | 100% 0 to 1.68K | |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Jan-17 | Option Exercise | 185 | $7.56 | $1,398.60 | 100% 0 to 0.18K | |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Jan-17 | Market Option Sale (Planned) | 185 | $36.40 | $6,734.00 | (100%) 0.18K to 0 | (27%) |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Jan-17 | Market Option Sale (Planned) | 718 | $36.25 | $26,027.50 | (100%) 0.72K to 0 | (28%) |
| 04-Jan-17 4:25 PM View: | Kuca Bernice Head,Clin. and Reg. Operations | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Jan-17 | Market Sale (Planned) | 772 | $36.25 | $27,985.00 | (2%) 40.86K to 40.09K | (28%) |
| 04-Jan-17 4:24 PM View: | Dallas Matthew D Chief Financial Officer | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Jan-17 | Market Sale (Planned) | 1,473 | $36.25 | $53,396.20 | (4%) 41.6K to 40.13K | (28%) |
| 05-Jan-17 4:35 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Jan-17 | Option Exercise | 718 | $6.75 | $4,846.50 | 100% 0 to 0.72K | |
| 05-Dec-16 4:39 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Dec-16 | Option Exercise | 1,864 | $9.76 | $18,186.20 | 100% 0 to 1.86K | |
| 05-Dec-16 4:41 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Dec-16 | Option Exercise | 3,756 | -- | -- | 1% 252.01K to 255.77K | |
| 05-Dec-16 4:41 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Dec-16 | Market Option Sale (Planned) | 1,502 | $38.75 | $58,202.50 | (< 1%) 255.77K to 254.27K | (15%) |
| 05-Dec-16 4:39 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Dec-16 | Market Option Sale (Planned) | 1,864 | $38.75 | $72,230.00 | (100%) 1.86K to 0 | (15%) |
| 01-Dec-16 4:45 PM View: | Kuca Bernice Head,Clin. and Reg. Operations | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Dec-16 | Market Sale (Planned) | 772 | $35.22 | $27,190.00 | (2%) 41.63K to 40.86K | (26%) |
| 05-Dec-16 4:39 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Dec-16 | Option Exercise | 719 | $6.75 | $4,853.25 | 100% 0 to 0.72K | |
| 01-Dec-16 4:43 PM View: | Dallas Matthew D Chief Financial Officer | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Dec-16 | Market Sale (Planned) | 1,473 | $35.17 | $51,801.10 | (3%) 43.07K to 41.6K | (26%) |
| 05-Dec-16 4:39 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Dec-16 | Market Option Sale (Planned) | 719 | $35.22 | $25,322.50 | (100%) 0.72K to 0 | (26%) |
| 07-Nov-16 4:24 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 07-Nov-16 | Market Option Sale (Planned) | 1,677 | $28.52 | $47,830.10 | (100%) 1.68K to 0 | (46%) |
| 07-Nov-16 4:26 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 07-Nov-16 | Market Option Sale (Planned) | 1,502 | $28.57 | $42,916.90 | (< 1%) 250.42K to 248.92K | (46%) |
| 07-Nov-16 4:24 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 07-Nov-16 | Option Exercise | 1,677 | $10.00 | $16,770.00 | 100% 0 to 1.68K | |
| 07-Nov-16 4:26 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Nov-16 | Option Exercise | 3,755 | -- | -- | 2% 246.67K to 250.42K | |
| 07-Nov-16 4:24 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Nov-16 | Option Exercise | 185 | $7.56 | $1,398.60 | 100% 0 to 0.18K | |
| 07-Nov-16 4:24 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Nov-16 | Market Option Sale (Planned) | 185 | $28.95 | $5,355.75 | (100%) 0.18K to 0 | (44%) |
| 01-Nov-16 4:28 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Nov-16 | Option Exercise | 719 | $6.75 | $4,853.25 | 100% 0 to 0.72K | |
| 01-Nov-16 4:28 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Nov-16 | Market Option Sale (Planned) | 719 | $30.00 | $21,570.00 | (100%) 0.72K to 0 | (39%) |
| 05-Oct-16 4:19 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Oct-16 | Market Option Sale (Planned) | 1,502 | $37.08 | $55,694.20 | (< 1%) 248.17K to 246.67K | (12%) |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Oct-16 | Market Option Sale (Planned) | 1,677 | $37.08 | $62,183.20 | (100%) 1.68K to 0 | (12%) |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Oct-16 | Option Exercise | 1,677 | $10.00 | $16,770.00 | 100% 0 to 1.68K | |
| 05-Oct-16 4:19 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 05-Oct-16 | Option Exercise | 3,755 | -- | -- | 2% 244.41K to 248.17K | |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Oct-16 | Option Exercise | 185 | $7.56 | $1,398.60 | 100% 0 to 0.18K | |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 04-Oct-16 | Market Option Sale (Planned) | 185 | $36.41 | $6,735.85 | (100%) 0.18K to 0 | (14%) |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Oct-16 | Option Exercise | 719 | $6.75 | $4,853.25 | 100% 0 to 0.72K | |
| 05-Oct-16 4:17 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Oct-16 | Market Option Sale (Planned) | 719 | $37.74 | $27,135.10 | (100%) 0.72K to 0 | (10%) |
| 16-Sep-16 4:45 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 14-Sep-16 | Market Sale (Planned) | 6,000 | $23.32 | $139,946.00 | (2%) 250.41K to 244.41K | (79%) |
| 13-Sep-16 11:48 AM View: | Novo A/s 10% Owner | Colucid Pharmaceuticals, Inc. (CLCD) | 09-Sep-16 | Private Purchase | 100,000 | $20.00 | $2,000,000.00 | 3% 3.06M to 3.16M | |
| 13-Sep-16 4:27 PM View: | Domain Partners Vi, L.P. 10% Owner | Colucid Pharmaceuticals, Inc. (CLCD) | 09-Sep-16 | Disposition (other) | 1,943,110 | -- | -- | (100%) 1.94M to 0 | |
| 07-Sep-16 5:56 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 07-Sep-16 | Market Option Sale (Planned) | 2,254 | $22.38 | $50,454.90 | (< 1%) 255.41K to 253.16K | (86%) |
| 07-Sep-16 5:56 PM View: | Mathers Thomas P. Chief Executive Officer Director | Colucid Pharmaceuticals, Inc. (CLCD) | 07-Sep-16 | Market Sale (Planned) | 2,746 | $22.38 | $61,468.10 | (1%) 253.16K to 250.41K | (86%) |
| 07-Sep-16 5:59 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 06-Sep-16 | Market Option Sale (Planned) | 3,735 | $19.50 | $72,832.50 | (100%) 3.73K to 0 | (114%) |
| 07-Sep-16 5:59 PM View: | Hogan Linda C. Head, Bus. Dev. and Strategy | Colucid Pharmaceuticals, Inc. (CLCD) | 06-Sep-16 | Option Exercise | 45,001 | $9.45 | $425,075.00 | 100% 0 to 45.0K |
